Literature DB >> 18417588

A filovirus-unique region of Ebola virus nucleoprotein confers aberrant migration and mediates its incorporation into virions.

Wei Shi1, Yue Huang, Mark Sutton-Smith, Berangere Tissot, Maria Panico, Howard R Morris, Anne Dell, Stuart M Haslam, Jeffrey Boyington, Barney S Graham, Zhi-Yong Yang, Gary J Nabel.   

Abstract

The Ebola virus nucleoprotein (NP) is an essential component of the nucleocapsid, required for filovirus particle formation and replication. Together with virion protein 35 (VP35) and VP24, this gene product gives rise to the filamentous nucleocapsid within transfected cells. Ebola virus NP migrates aberrantly, with an apparent molecular mass of 115 kDa, although it is predicted to encode an approximately 85-kDa protein. In this report, we show that two domains of this protein determine this aberrant migration and that this region mediates its incorporation into virions. These regions, amino acids 439 to 492 and amino acids 589 to 739, alter the mobility of Ebola virus NP by sodium dodecyl sulfate-polyacrylamide gel electrophoresis by 5 and 15 kDa, respectively, and confer similar effects on a heterologous protein, LacZ, in a position-independent fashion. Furthermore, when coexpressed with VP40, VP35, and VP24, this region mediated incorporation of NP into released viruslike particles. When fused to chimeric paramyxovirus NPs derived from measles or respiratory syncytial virus, this domain directed these proteins into the viruslike particle. The COOH-terminal NP domain comprises a conserved highly acidic region of NP with predicted disorder, distinguishing Ebola virus NPs from paramyxovirus NPs. The acidic character of this domain is likely responsible for its aberrant biochemical properties. These findings demonstrate that this region is essential for the assembly of the filamentous nucleocapsids that give rise to filoviruses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18417588      PMCID: PMC2447054          DOI: 10.1128/JVI.02731-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  The PSIPRED protein structure prediction server.

Authors:  L J McGuffin; K Bryson; D T Jones
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

2.  p53 inhibition by the LANA protein of KSHV protects against cell death.

Authors:  J Friborg; W Kong; M O Hottiger; G J Nabel
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

3.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States.

Authors:  T W Geisbert; P B Jahrling; M A Hanes; P M Zack
Journal:  J Comp Pathol       Date:  1992-02       Impact factor: 1.311

5.  A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70K U1 snRNP protein.

Authors:  C C Query; R C Bentley; J D Keene
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

6.  The nucleoprotein of Marburg virus is phosphorylated.

Authors:  S Becker; S Huppertz; H D Klenk; H Feldmann
Journal:  J Gen Virol       Date:  1994-04       Impact factor: 3.891

7.  Development of a preventive vaccine for Ebola virus infection in primates.

Authors:  N J Sullivan; A Sanchez; P E Rollin; Z Y Yang; G J Nabel
Journal:  Nature       Date:  2000-11-30       Impact factor: 49.962

8.  Aberrant mobility phenomena of the DNA repair protein XPA.

Authors:  L M Iakoucheva; A L Kimzey; C D Masselon; R D Smith; A K Dunker; E J Ackerman
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

9.  Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease.

Authors:  H J Schnittler; F Mahner; D Drenckhahn; H D Klenk; H Feldmann
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Prediction and functional analysis of native disorder in proteins from the three kingdoms of life.

Authors:  J J Ward; J S Sodhi; L J McGuffin; B F Buxton; D T Jones
Journal:  J Mol Biol       Date:  2004-03-26       Impact factor: 5.469

View more
  23 in total

1.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

2.  Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription.

Authors:  Andrey Ivanov; Palaniappan Ramanathan; Christian Parry; Philipp A Ilinykh; Xionghao Lin; Michael Petukhov; Yuri Obukhov; Tatiana Ammosova; Gaya K Amarasinghe; Alexander Bukreyev; Sergei Nekhai
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

3.  Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain.

Authors:  Daisy W Leung; Reed S Shabman; Mina Farahbakhsh; Kathleen C Prins; Dominika M Borek; Tianjiao Wang; Elke Mühlberger; Christopher F Basler; Gaya K Amarasinghe
Journal:  J Mol Biol       Date:  2010-04-24       Impact factor: 5.469

4.  An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions.

Authors:  Daisy W Leung; Dominika Borek; Priya Luthra; Jennifer M Binning; Manu Anantpadma; Gai Liu; Ian B Harvey; Zhaoming Su; Ariel Endlich-Frazier; Juanli Pan; Reed S Shabman; Wah Chiu; Robert A Davey; Zbyszek Otwinowski; Christopher F Basler; Gaya K Amarasinghe
Journal:  Cell Rep       Date:  2015-04-09       Impact factor: 9.423

5.  Molecular architecture of the nucleoprotein C-terminal domain from the Ebola and Marburg viruses.

Authors:  Laura E Baker; Jeffrey F Ellena; Katarzyna B Handing; Urszula Derewenda; Darkhan Utepbergenov; Daniel A Engel; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-01-01       Impact factor: 7.652

6.  Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus.

Authors:  Tengfei Zhu; Hao Song; Ruchao Peng; Yi Shi; Jianxun Qi; George F Gao
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

7.  Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.

Authors:  Daisy W Leung; Kathleen C Prins; Dominika M Borek; Mina Farahbakhsh; JoAnn M Tufariello; Parameshwaran Ramanan; Jay C Nix; Luke A Helgeson; Zbyszek Otwinowski; Richard B Honzatko; Christopher F Basler; Gaya K Amarasinghe
Journal:  Nat Struct Mol Biol       Date:  2010-01-17       Impact factor: 15.369

8.  Unexpected inheritance: multiple integrations of ancient bornavirus and ebolavirus/marburgvirus sequences in vertebrate genomes.

Authors:  Vladimir A Belyi; Arnold J Levine; Anna Marie Skalka
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

9.  Development of RNA aptamers targeting Ebola virus VP35.

Authors:  Jennifer M Binning; Tianjiao Wang; Priya Luthra; Reed S Shabman; Dominika M Borek; Gai Liu; Wei Xu; Daisy W Leung; Christopher F Basler; Gaya K Amarasinghe
Journal:  Biochemistry       Date:  2013-11-14       Impact factor: 3.162

10.  Ebola Virus Does Not Induce Stress Granule Formation during Infection and Sequesters Stress Granule Proteins within Viral Inclusions.

Authors:  Emily V Nelson; Kristina M Schmidt; Laure R Deflubé; Sultan Doğanay; Logan Banadyga; Judith Olejnik; Adam J Hume; Elena Ryabchikova; Hideki Ebihara; Nancy Kedersha; Taekjip Ha; Elke Mühlberger
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.